105
Participants
Start Date
July 31, 2012
Primary Completion Date
September 30, 2019
Study Completion Date
September 30, 2020
Liraglutide
1.8 mg liraglutide
Placebo
Liraglutide without the GLP-1 analogue
Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Hellerup
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Rigshospitalet, Denmark
OTHER
Hvidovre University Hospital
OTHER
Herlev Hospital
OTHER
Hillerod Hospital, Denmark
OTHER
University of Copenhagen
OTHER
The Novo Nordisk Foundation Center for Basic Metabolic Research
OTHER
Aarhus University Hospital
OTHER
Tina Vilsboll
OTHER